Incidence and Risk Factors for Early Hepatotoxicity and Its Impact on Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplantation-Reference-Cited by-同舟云学术

Incidence and Risk Factors for Early Hepatotoxicity and Its Impact on Survival in Patients with Myelofibrosis Undergoing Allogeneic Hematopoietic Cell Transplantation

Published:2012-10 Issue:10 Volume:18 Page:1589-1599
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Wong Kit Man,Atenafu Eshetu G.,Kim Dennis,Kuruvilla John,Lipton Jeffrey H.,Messner Hans,Gupta Vikas

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference40 articles.

1. Allogeneic hematopoietic cell transplantation for patients with myelofibrosis;Zang;Curr Opin Hematol,2009

2. Severe hepatocellular injury after hematopoietic cell transplant: incidence, etiology and outcome;Sakai;Bone Marrow Transplant,2009

3. Liver disease is a major cause of mortality following allogeneic bone marrow transplantation;El-Sayed;Eur J Gastroenterol Hepatol,2004

4. Liver disease during the first post-transplant year in bone marrow transplantation recipients: retrospective study;Kim;Bone Marrow Transplant,2000

5. Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy;Ho;Eur J Gastroenterol Hepatol,2004

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: updated recommendations by the EBMT/ELN International Working Group;The Lancet Haematology;2024-01

2. Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT;British Journal of Haematology;2023-11-28

3. How I treat transplant-eligible patients with myelofibrosis;Blood;2023-11-16

4. Screening for signs of portal hypertension by esophagogastroduodenoscopy in patients with BCR‐ABL negative myeloproliferative neoplasms;American Journal of Hematology;2023-02-06

5. Splenomegaly in patients with primary or secondary myelofibrosis who are candidates for allogeneic hematopoietic cell transplantation: a Position Paper on behalf of the Chronic Malignancies Working Party of the EBMT;The Lancet Haematology;2023-01